John E. Weldon - Concepedia

Author

John E. Weldon

National Cancer Institute ORCID

Also Known As

J. E. Weldon, John E Weldon, John E. Weldon, John Weldon, Weldon, John

Publications

Citations

H-Index

Concepts

All Affiliations

National Cancer Institute National Institutes of Health Center for Cancer Research Towson University MRC Laboratory of Molecular Biology

About

John E. Weldon is an author at National Cancer Institute specializing in medicine, immunology, and immunomodulation.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	7	7	347
2	Natural Sciences	3	3	78
3	Allergy	3	3	237
4	Biochemistry	3	3	78
5	Engineering	2	2	124

John E. Weldon

Publications

783

Citations

H-Index

Page 1

	Year	Citations
A protease-resistant immunotoxin against CD22 with greatly increased activity against CLL and diminished animal toxicity John E. Weldon, Laiman Xiang, Oleg Chertov, Blood	2008	164
Recombinant immunotoxin against B-cell malignancies with no immunogenicity in mice by removal of B-cell epitopes Masanori Onda, Richard Beers, Laiman Xiang, Proceedings of the National Academy of Sciences B-cell MalignanciesHumoral ResponseImmunologyImmunodominancePathology	2011	105
A Recombinant Immunotoxin against the Tumor-Associated Antigen Mesothelin Reengineered for High Activity, Low Off-Target Toxicity, and Reduced Antigenicity John E. Weldon, Laiman Xiang, Jingli Zhang, Molecular Cancer Therapeutics Reengineered Ss1pEngineeringImmunotoxicologyImmunologyImmunotherapeutics	2012	92
Identification and elimination of an immunodominant T-cell epitope in recombinant immunotoxins based on<i>Pseudomonas</i>exotoxin A Ronit Mazor, Aaron Vassall, Jaime Eberle-Singh, Proceedings of the National Academy of Sciences	2012	87
The Gene ygdP, Associated with the Invasiveness ofEscherichia coli K1, Designates a Nudix Hydrolase, Orf176, Active on Adenosine (5′)-Pentaphospho-(5′)-adenosine (Ap5A) Maurice Bessman, Joseph D. Walsh, Christopher Dunn, Journal of Biological Chemistry	2001	77
Pigment Epithelium-derived Factor Binds to Hyaluronan S. Patricia Becerra, Alberto Pérez‐Mediavilla, John E. Weldon, Journal of Biological Chemistry	2008	50
A Recombinant Immunotoxin Targeting CD22 With Low Immunogenicity, Low Nonspecific Toxicity, and High Antitumor Activity in Mice Johanna K. Hansen, John E. Weldon, Laiman Xiang, Journal of Immunotherapy ImmunologyImmunologic MechanismAntigen ProcessingImmune SystemImmunotherapy	2010	40
Glycosaminoglycans in human retinoblastoma cells: Heparan sulfate, a modulator of the pigment epithelium-derived factor-receptor interactions Elena Alberdi, John E. Weldon, S. Patricia Becerra BMC Biochemistry	2003	39
Structure and properties of a truely apo form of AraC dimerization domain John E. Weldon, Michael E. Rodgers, Christopher Larkin, Proteins Structure Function and Bioinformatics BiochemistryProtein AssemblyProtein FoldingArac Dimerization DomainDimeric Form	2006	34
Designing the Furin-Cleavable Linker in Recombinant Immunotoxins Based on <i>Pseudomonas</i> Exotoxin A John E. Weldon, Martin Skarzynski, Jamy A. Therres, Bioconjugate Chemistry BacteriologyFurin LinkersMolecular BiologyChemical BiologyBacterial Pathogens	2015	33

Page 1